Mulberry leaf extract improves postprandial glucose response in prediabetic subjects: A randomized, double-blind placebo-controlled trial

Journal of Medicinal Food

Volumn 18, Issue 3, 2015, Pages 306-313

  Kim, Ji Yeon ^a   Ok, Hyang Mok ^b   Kim, Joohee ^b   Park, Seok Won ^c   Kwon, Sung Won ^c   Kwon, Oran ^b  

^a Seoul National University of Science and Technology   (South Korea)

^b Ewha Womans University   (South Korea)

^c CHA University   (South Korea)

Author keywords

1 deoxynojirimycin; mulberry leaf aqueous extract; postprandial glycemic control

Indexed keywords

ANTIDIABETIC AGENT; C PEPTIDE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; MULBERRY EXTRACT; PLACEBO; GLUCOSE BLOOD LEVEL; PLANT EXTRACT;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BREAD; CALORIC INTAKE; CARBOHYDRATE INTAKE; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; DIETARY FIBER; DOUBLE BLIND PROCEDURE; FAT INTAKE; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; MALE; MULBERRY; PLANT LEAF; POSTPRANDIAL STATE; PRIORITY JOURNAL; PROTEIN INTAKE; RANDOMIZED CONTROLLED TRIAL; STRAWBERRY; SUPPLEMENTATION; AREA UNDER THE CURVE; BIOASSAY; BLOOD; DIET SUPPLEMENTATION; GLUCOSE INTOLERANCE; METABOLISM; MIDDLE AGED; MORUS; PHYTOTHERAPY; PREDIABETIC STATE;

MORUS (PLANT);

AREA UNDER CURVE; BIOLOGICAL ASSAY; BLOOD GLUCOSE; C-PEPTIDE; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FASTING; FEMALE; GLUCOSE INTOLERANCE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; MORUS; PHYTOTHERAPY; PLANT EXTRACTS; PLANT LEAVES; POSTPRANDIAL PERIOD; PREDIABETIC STATE;

EID: 84924177034     PISSN: 1096620X     EISSN: 15577600     Source Type: Journal    
DOI: 10.1089/jmf.2014.3160     Document Type: Article

References (41)

1. Barr EL, Zimmet PZ, Welborn TA, et al. Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab). Circulation 2007;116:151-157
2. Barr EL, Boyko EJ, Zimmet PZ, Wolfe R, Tonkin AM, Shaw JE. Continuous relationships between non-diabetic hyperglycaemia and both cardiovascular disease and all-cause mortality: the Australian Diabetes, Obesity, and Lifestyle (AusDiab) study. Diabetologia 2009;52:415-424
3. Cavalot F, Petrelli A, Traversa M, et al. Postprandial blood glucose is a stronger predictor of cardiovascular events than fasting blood glucose in type 2 diabetes mellitus, particularly in women: lessons from the San Luigi Gonzaga Diabetes Study. J Clin Endocrinol Metab 2006;91:813-819
4. Esposito K, Ciotola M, Carleo D, et al. Post-meal glucose peaks at home associate with carotid intima-media thickness in type 2 diabetes. J Clin Endocrinol Metab 2008;93:1345-1350
5. Hanefeld M, Fischer S, Julius U, et al. Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up. Diabetologia 1996;39:1577-1583
6. Lefèbvre PJ, Scheen AJ. The postprandial state and risk of cardiovascular disease. Diabet Med 1998;15:S63-S68
7. Scognamiglio R, Negut C, De Kreutzenberg SV, Tiengo A, Avogaro A. Effects of different insulin regimes on postprandial myocardial perfusion defects in type 2 diabetic patients. Diabet Care 2006;29:95-100
8. Shimabukuro M, Higa N, Chinen I, Yamakawa K, Takasu N. Effects of a single administration of acarbose on postprandial glucose excursion and endothelial dysfunction in type 2 diabetic patients: a randomized crossover study. J Clin Endocrinol Metab 2006;91:837-842
9. Wascher TC, Schmoelzer I, Wiegratz A, et al. Reduction of postchallenge hyperglycaemia prevents acute endothelial dysfunction in subjects with impaired glucose tolerance. Eur J Clin Invest 2005;35:551-557
10. HsuehWA, Orloski L,Wyne K. Prediabetes: the importance of early identification and intervention. Postgrad Med 2010;122:129-143
11. Standl E, Schnell O, Ceriello A. Postprandial hyperglycemia and glycemic variability: should we care?. Diabetes Care 2011;34:S120-S127
12. Standl E, Schnell O. Alpha-glucosidase inhibitors 2012-cardiovascular considerations and trial evaluation. Diab Vasc Dis Res 2012;9:163-169
13. Asano N, Yamashita T, Yasuda K, et al. Polyhydroxylated alkaloids isolated from mulberry trees (Morus alba L.) and silkworms (Bombyx mori L.). J Agric Food Chem 2001;49:4208-4213
14. Miyahara C, Miyazawa M, Satoh S, Sakai A, Mizusaki S. Inhibitory effects of mulberry leaf extract on postprandial hyperglycemia in normal rats. J Nutr Sci Vitaminol 2004;50:161-164
15. Naowaboot J, Pannangpetch P, Kukongviriyapan V, Kongyingyoes B, Kukongviriyapan U. Antihyperglycemic, antioxidant and antiglycation activities of mulberry leaf extract in streptozotocin-induced chronic diabetic rats. Plant Foods Hum Nutr 2009;64:116-121
16. Park JM, Bong HY, Jeong HI, Kim YK, Kim JY, Kwon O. Postprandial hypoglycemic effect of mulberry leaf in Goto-Kakizaki rats and counterpart control Wistar rats. Nutr Res Pract 2009;3:272-278
17. Zhang M, Chen M, Zhang HQ, Sun S, Xia B, Wu FH. In vivo hypoglycemic effects of phenolics from the root bark of Morus alba. Fitoterapia 2009;80:475-477
18. Song W, Wang HJ, Bucheli P, Zhang, PF, Wei DZ, Lu YH. Phytochemical profiles of different mulberry (Morus sp.) species from China. J Agric Food Chem 2009;57:9133-9140
19. Chae JY, Lee JY, Hoang IS, et al. Analysis of functional components of leaves of different mulberry cultivars. J Korean Soc Food Sci Nutr 2003;32:15-21
20. Kwon HJ, Chung JY, Kim JY, Kwon O. Comparison of 1-deoxynojirimycin and aqueous mulberry leaf extract with emphasis on postprandial hypoglycemic effects: in vivo and in vitro studies. J Agric Food Chem 2011;59:3014-3019
21. Kim JY, Choi BK, Jung MJ, Wee JH, Chung KH, Kwon O. Mulberry leaf water extract ameliorates insulin sensitivity in high fat or high sucrose diet induced overweight rats. J Korean Soc Appl Biol Chem 2011;54:612-618
22. Chung HI, Kim J, Kim JY, Kwon O. Acute intake of mulberry leaf aqueous extract affects postprandial glucose response after maltose loading: randomized double-blind placebo-controlled pilot study. J Funct Foods 2013;5:1502-1506
23. Asai A, Nakagawa K, Higuchi O, et al. Effect of mulberry leaf extract with enriched 1-deoxynojirimycin content on postprandial glycemic control in subjects with impaired glucose metabolism. J Diabetes Invest 2011;2:318-323
24. Mudra M, Ercan-Fang N, Zhong L, Furne J, Levitt M. Influence of mulberry leaf extract on the blood glucose and breath hydrogen response to ingestion of 75 g sucrose by type 2 diabetic and control subjects. Diabet Care 2007;30:1272-1274
25. Nakamura M, Nakamura S, Oku T. Suppressive response of confections containing the extractive from leaves of Morus Alba on postprandial blood glucose and insulin in healthy human subjects. Nutr Metab 2009;6:29
26. Kim JW, Kim SU, Lee HS, Kim I, Ahn MY, Ryu KS. Determination of 1-deoxynojirimycin in Morus alba L. leaves by derivatization with 9-fluorenylmethyl chloroformate followed by reversed-phase high-performance liquid chromatography. J Chromatogr A 2003;1002:93-99
27. Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Ann Intern Med 2010;152:726-732
28. Wolever TM, Jenkins DJ, Jenkins AL, Josse RG. The glycemic index: methodology and clinical implications. Am J Clin Nutr 1991;54:846-854
29. Kimura T, Nakagawa K, Kubota H, et al. Food-grade mulberry powder enriched with 1-deoxynojirimycin suppresses the elevation of postprandial blood glucose in humans. J Agric Food Chem 2007;55:5869-5874
30. Dandona P, Aljada A, Chaudhuri A, Mohanty P, Garg R. Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation 2005;111:1448-1454
31. Ludwig DS. The glycemic index: physiological mechanisms relating to obesity, diabetes, and cardiovascular disease. J Am Med Assoc 2002;287:2414-2423
32. Derosa G, Maffioli P. Efficacy and safety profile evaluation of acarbose alone and in association with other antidiabetic drugs: a systematic review. Clin Ther 2012;34:1221-1236
33. Van De Laar FA, Lucassen PL, Akkermans RP, Van De Lisdonk EH, Rutten GE, Van Weel C. Alpha-glucosidase inhibitors for type 2 diabetes mellitus. Cochrane Database Syst Rev 2005;CD003639
34. Van De Laar FA, Lucassen PL, Akkermans RP, Van De Lisdonk EH, De Grauw WJ. Alpha-glucosidase inhibitors for people with impaired glucose tolerance or impaired fasting blood glucose. Cochrane Database Syst Rev 2006;CD005061
35. Balfour JA, McTavish D. Acarbose. An update of its pharmacology and therapeutic use in diabetes mellitus. Drugs 1993;46:1025-1054
36. Mertes G. Safety and efficacy of acarbose in the treatment of Type 2 diabetes: data from a 5-year surveillance study. Diabetes Res Clin Pract 2001;52:193-204
37. Gao J, Xu P, Wang Y, Wang Y, Hochstetter D. Combined effects of green tea extracts, green tea polyphenols or epigallocatechin gallate with acarbose on inhibition against a-amylase and aglucosidase in vitro. Molecules 2013;18:11614-11623
38. Chung KO, Kim BY, Lee MH, et al. In-vitro and in-vivo antiinflammatory effect of oxyresveratrol from Morus alba L. J Pharm Pharmacol 2003;55:1695-1700
39. Katsube T, Yamasaki M, Shiwaku K, et al. Effect of flavonol glycoside in mulberry (Morus alba L.) leaf on glucose metabolism and oxidative stress in liver in diet-induced obese mice. J Sci Food Agric 2010;90:2386-2392
40. Hansawasdi C, Kawabata J. Alpha-glucosidase inhibitory effect of mulberry (Morus alba) leaves on Caco-2. Fitoterapia 2006;77:568-573
41. Bantle JP, Wylie-Rosett J, Albright AL, et al. American Diabetes Association. Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association. Diabetes Care 2008;31:S61-S78